Etoposide Injection

  • Generic name

    etoposide

  • Brand reference

    Vepesid®

  • Strength

    20 mg/mL

  • DIN

    02080036

  • Therapeutic class

    Antineoplastic Agent

  • Therapeutic area

    Oncology

  • Package size

    Vial 50 mL
    Vial 10 mL
    Vial 5 mL
    Vial 25 mL

  • Product code

    72102-0033
    72102-0010
    72102-0005
    72102-0025

  • UPC

    068510645333
    068510645104
    068510645050
    068510645258

  • Generic name:

    etoposide

  • Brand reference:

    Vepesid®

  • Product code:

    72102-0033
    72102-0010
    72102-0005
    72102-0025

  • Strength

    20 mg/mL

  • DIN

    02080036

  • UPC:

    068510645333
    068510645104
    068510645050
    068510645258

  • Therapeutic class

    Antineoplastic Agent

  • Therapeutic area:

    Oncology

  • Package size:

    Vial 50 mL
    Vial 10 mL
    Vial 5 mL
    Vial 25 mL

Composition

Active ingredient

etoposide


Non-medicinal ingredients

2 mg citric acid, anhydrous; 80 mg polysorbate 80; 241 mg absolute ethanol and polyethylene glycol 300.

Product characteristics

  • Dosage form

    solution for injection

  • Shape

    -

  • Marking 1

    -

  • Marking 2

    -

  • Colour

    -

  • Secondary colour

    -

  • Scored

    -

  • Flavour

    -

  • Gluten

    currently not available

  • Latex

    no

Disclaimers

All information about raw materials and/or allergen information for Teva Canada’s products is obtained from our suppliers and/or third-party affiliates and is based on their records.

Please be advised that the Medical Information department is not always notified of change in third-party affiliates and/or change in suppliers of the active and inactive ingredients that may occur over time, and all information provided herein is based on our last records on file.

Our manufacturing sites are not certified gluten-free. Raw materials and finished products are not tested for the presence of gluten. Therefore, the presence of trace amounts of gluten in the raw materials and in the finished products cannot be excluded.

"Latex" refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging, or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process; however, this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and/or packaging facilities may be wearing latex gloves.

Product monograph/consumer information leaflet


View monograph

Notice

We are modifying our product names to align with our corporate name change. Accordingly, please expect product monographs to contain the “Novo-”, “ratio-”, “ACT”, "CO" prefix or the new “Teva” prefix. These prefixes may be used interchangeably on the website.

Should you have any questions about our product names or our corporate name change, please do not hesitate to contact us. Our Customer Care department can be reached at 1-800-268-4127 regarding your inquiry.